These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Björgvinsdóttir H, Ding C, Pech N, Gifford MA, Li LL, Dinauer MC. Blood; 1997 Jan 01; 89(1):41-8. PubMed ID: 8978275 [Abstract] [Full Text] [Related]
5. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Dinauer MC, Gifford MA, Pech N, Li LL, Emshwiller P. Blood; 2001 Jun 15; 97(12):3738-45. PubMed ID: 11389011 [Abstract] [Full Text] [Related]
16. Genetic, biochemical, and clinical features of chronic granulomatous disease. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Medicine (Baltimore); 2000 May 01; 79(3):170-200. PubMed ID: 10844936 [Abstract] [Full Text] [Related]
17. Advances in the treatment of Chronic Granulomatous Disease by gene therapy. Ott MG, Seger R, Stein S, Siler U, Hoelzer D, Grez M. Curr Gene Ther; 2007 Jun 01; 7(3):155-61. PubMed ID: 17584034 [Abstract] [Full Text] [Related]
18. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Becker S, Wasser S, Hauses M, Hossle JP, Ott MG, Dinauer MC, Ganser A, Hoelzer D, Seger R, Grez M. Hum Gene Ther; 1998 Jul 20; 9(11):1561-70. PubMed ID: 9694155 [Abstract] [Full Text] [Related]